These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 27245191

  • 1. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM, Martin BA, Hu RJ.
    Am J Psychiatry; 2016 Jun 01; 173(6):643. PubMed ID: 27245191
    [No Abstract] [Full Text] [Related]

  • 2. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW, Bogers JP, Giltay EJ.
    Gen Hosp Psychiatry; 2013 Jun 01; 35(5):576.e11-2. PubMed ID: 23395419
    [Abstract] [Full Text] [Related]

  • 3. [Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors].
    van Melick EJ, Touw DJ, Haak HL.
    Ned Tijdschr Geneeskd; 1995 Nov 25; 139(47):2437-40. PubMed ID: 8524426
    [Abstract] [Full Text] [Related]

  • 4. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG, Stewart JT.
    South Med J; 2008 Jun 25; 101(6):639-40. PubMed ID: 18475227
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V, Denton K, Borra D, Pulluri M, Sharma A.
    Psychooncology; 2013 Jul 25; 22(7):1674-5. PubMed ID: 23059755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic dilemmas in treatment-resistant bipolar patients.
    Bota RG, Sagduyu K.
    South Med J; 2008 Jun 25; 101(6):584. PubMed ID: 18475231
    [No Abstract] [Full Text] [Related]

  • 11. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I, Bezchlibnyk-Butler K, Wong L.
    Can J Psychiatry; 1996 Jun 25; 41(5):280-4. PubMed ID: 8793147
    [Abstract] [Full Text] [Related]

  • 12. Association between clozapine-induced agranulocytosis and HLA subtyping.
    Lopez-Garcia P, Teresa Rodriguez J, De Castro P, Landecho I, Zapata R.
    J Clin Psychiatry; 2006 Oct 25; 67(10):1652-3. PubMed ID: 17107265
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May 25; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. G-CSF plasma levels in clozapine-induced neutropenia.
    Jauss M, Pantel J, Werle E, Schröder J.
    Biol Psychiatry; 2000 Dec 01; 48(11):1113-5. PubMed ID: 11094146
    [Abstract] [Full Text] [Related]

  • 20. The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF).
    Chengappa KN, Gopalani A, Haught MK, McChesney K, Baker RW, Schooler NR.
    Psychopharmacol Bull; 1996 Dec 01; 32(1):111-21. PubMed ID: 8927660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.